Pioglitazone and bladder cancer risk: Examining the evidence.

MLA

Taylor, James R. “Pioglitazone and Bladder Cancer Risk: Examining the Evidence.” Endocrine Today, vol. 10, no. 5, May 2012, p. 40. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=86260034&authtype=sso&custid=ns315887.

APA

Taylor, J. R. (2012). Pioglitazone and bladder cancer risk: Examining the evidence. Endocrine Today, 10(5), 40.

Chicago

Taylor, James R. 2012. “Pioglitazone and Bladder Cancer Risk: Examining the Evidence.” Endocrine Today 10 (5): 40. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=86260034&authtype=sso&custid=ns315887.